X @The Wall Street Journal

Regulatory Concerns - FDA Commissioner Marty Makary's commitment to accelerating life-saving drugs is questioned [1] - FDA's actions, such as hindering an immunotherapy shot for advanced melanoma, raise concerns [1] - Slow progress on a treatment for a rare disease by the FDA is noted [1]